Rhetoric or a real threat? A week in pharma politics with Pelosi, Biden, Sanders and more

Is pharma really heading toward a pivotal point on drug pricing? To hear politicians talk, particularly 2020 candidates, there's no doubt. Each Monday, we'll track developments in Washington and beyond that could affect how drugmakers operate.